… Leqvio (inclisiran) has passed the Pharmaceutical Reimbursement Evaluation Committee (PREC) on … rediscuss Ipsen's Bylvay (odevixibat), which was designated an orphan drug … drug will be reimbursed pending price negotiations with the National Health …

… proven track record in drug development will be invaluable … its promising pipeline of drug candidates have the potential … Vifor Pharma, Ipsen and Telix, and has served as chief medical … design, regulatory strategy and drug development across both emerging …

Industry veteran brings extensive oncology drug development expertise and experience … ’s clinical activities, providing medical and operational leadership for the … Head of Oncology Development at Ipsen Pharmaceuticals, where, amongst many programs, …

… fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation; global trends … inherent in new-medicine development, including obtaining regulatory approval; Ipsen’s ability …

… proposer nos médicaments aux patients dans plus de 80 pays. Ipsen est … la réglementation de l’industrie pharmaceutique et de la législation en … brevets d’Ipsen et d’autres protections concernant les médicaments novateurs ; l …

… is recognized both by healthcare professionals, patients, and caregivers … zero copays and free drugs for uninsured patients. Alkimbe … through the traditional pharmacy model, most pharmacies did not even … patients, including those on Medicare. For the first time …

… .S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA … & Johnson Innovative Medicine OLX 702A: OliX Pharmaceuticals STP 122G: Sirnaomics SGB … -mRNA platform. In April 2024, Ipsen and Skyhawk Therapeutics signed an …

… on developing improved antibody-drug conjugates (ADCs) for … research collaboration with Chugai Pharmaceutical, with a research collaboration … ADC technology from Innate Pharma. Taiho’s purchase … in January 2024. Ipsen and Foreseen Biotecnology partnered …

… sustainable way to access the medication,” said Perrault, who is trying … of new drugs. “Depending on Health Canada’s evaluation,” Bain said Ipsen would … some hope, and the pharmaceutical company and Health Canada is saying, ‘Sorry …

… Việt Nam through its IPSEN CHC entity. This office plays … . Mayoly is an independent French pharmaceutical group with an international footprint … historical areas of expertise: digestive health, dermocosmetics and manufacturing, including internationally …